Vietnam Cannabis Market

The formal Vietnam Cannabis Market is estimated at USD 5.6 million in 2025. The estimate covers hemp-seed personal care, seed-based nutrition, laboratory reference standards and specially permitted clinical inputs. It excludes illicit cannabis, recreational flower, domestic THC cultivation and unlicensed CBD consumer products. The market is therefore much smaller than Vietnam's population might suggest. A triangulated supply, operating-parameter and demand model places the 2025 confidence interval at USD 4.2 million to USD 7.1 million, with ingredient legality and product-count assumptions driving the range.

The market is projected to reach USD 12.0 million by 2031, implying a 13.6% CAGR from 2025. Growth is expected to come from broader hemp-seed beauty assortment, online specialty retail, laboratory testing inputs and a gradual rise in institutional procurement. The forecast does not assume recreational legalization or domestic commercial cannabis cultivation. Annual growth increases from 12.9% in 2026 to 14.8% in 2031 as documented products achieve wider distribution and institutional buyers account for a larger revenue share.

The profit pool will shift from low-ticket mass personal care toward premium natural products, institutional testing and controlled distribution services. Hemp-seed cosmetics remain the largest product group, but laboratories and regulated distributors offer stronger margins because buyers pay for accredited methods, certificates of analysis, chain-of-custody and import documentation. Institutional procurement rises from 14.2% of revenue in 2025 to 17.2% in 2031. E-commerce also gains share, but open marketplaces face higher delisting and counterfeit risk than retailer-controlled channels.

The decisive constraint is the prohibition of plant-touching cannabis commerce and the absence of a broad industrial-hemp or medical-cannabis pathway. Vietnam's controlled-substance rules make cultivation, trafficking and unauthorized use high-risk activities, so the formal market is limited to carefully documented seed derivatives, research inputs and any specially permitted medicines. Enforcement is active, including a 270 kg cannabis seizure in a 2025 trafficking case linked to cross-border logistics. Regulatory ambiguity also increases the cost of verifying ingredient identity and claims.

Vietnam ranks third among the selected peers by formal 2025 market size, behind Thailand and Malaysia but ahead of the Philippines and Indonesia in this report's comparable scope. Thailand remains structurally larger because decriminalization created an industry valued above USD 1 billion before medical-only tightening in 2025. Vietnam's 13.6% forecast CAGR is faster than Thailand's 6.5% because Vietnam starts from a very low base. Unlike Thailand, Vietnam has no plant-touching commercial channel, so peer comparisons must adjust for legal scope.

The strongest near-term demand driver is the combination of a large beauty market and digital product discovery. Vietnam's beauty and personal care market was valued at roughly USD 2.4 billion in 2023 and projected to reach USD 2.7 billion in 2027, while 79.8 million people used the internet at the start of 2025. These conditions allow compliant hemp-seed products to scale through specialty beauty chains and retailer websites. Demand alone is insufficient, however, because ingredient documentation and claim compliance determine whether products can be listed.

The largest upside would come from a formal industrial-hemp framework that defines permitted plant parts, THC testing thresholds, licensing, import documentation and finished-product standards. A separate named-patient or hospital-only route for registered cannabinoid medicines could add a higher-value clinical segment without opening recreational retail. Under the report's upside scenario, the market could reach USD 21.5 million by 2031, compared with USD 12.0 million in the base case. The investment trigger is regulatory clarity supported by accredited testing and traceability.